Professional Documents
Culture Documents
GUIDELINES
thromboembolism prophylaxis
Executive summary
Arash Afshari, Walter Ageno, Aamer Ahmed, Jacques Duranteau, David Faraoni,
Sibylle Kozek-Langenecker, Juan Llau, Jacky Nizard, Maurizio Solca, Jakob Stensballe,
Emmanuel Thienpont, Eleftherios Tsiridis, Linas Venclauskas and
Charles Marc Samama, for the ESA VTE Guidelines Task Force
From the Department of Anesthesia, Mother and Children’s Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark (AA), Department of Clinical and
Experimental Medicine, University of Insubria, Varese, Italy (WA), Department of Anaesthesia and Critical Care, Glenfield Hospital, University Hospitals of Leicester NHS
Trust, Leicester, UK (AA), Department of Anaesthesia and Intensive Care, Hôpitaux Universitaires Paris-Sud, Assistance Publique–Hôpitaux de Paris, Université Paris-Sud,
Hôpital de Bicêtre, UMRS 942, Paris, France (JD), Department of Anaesthesia and Pain Medicine, Hospital for Sick Children, University of Toronto, Toronto, Ontario,
Canada (DF), Sigmund Freud Private University and Department of Anaesthesia and Intensive Care, Evangelical Hospital Vienna, Vienna, Austria (SKL), Department of
Anaesthesiology and Critical Care Hospital Clinic, University of València, Spain (JL), Department of Obstetrics and Gynecology, Groupe hospitalier Pitié-Salpêtrière,
Assistance Publique–Hôpitaux de Paris, Paris, France (JN), European Society of Anaesthesiology, Brussels, Belgium (MS), Department of Anaesthesia, Centre for Head
and Orthopaedics, Rigshospitalet, University Hospital (JS), Section for Transfusion Medicine, Capitol Region Blood Bank, Copenhagen University Hospital, Copenhagen,
Denmark (JS), Orthopaedic Surgery, University Hospital Saint Luc, Brussels, Belgium (ET), Orthopaedic Surgery, Aristotle University Medical School, Thessaloniki, Greece
and Imperial College London Medical School, London, UK (ET), Department of Surgery, Lithuanian University of Health Sciences, Kaunas, Lithuania (LV) and Department of
Anaesthesia and Intensive Care, Cochin University Hospital, Assistance Publique–Hôpitaux de Paris, Université Paris Descartes, Paris, France (CMS)
Correspondence to Charles Marc Samama, MD, PhD, FCCP, Department of Anaesthesia and Intensive Care, Cochin University Hospital, Assistance Publique–Hôpitaux
de Paris, Université Paris Descartes, Paris, France
E-mail: marc.samama@aphp.fr
0265-0215 Copyright ß 2018 European Society of Anaesthesiology. All rights reserved. DOI:10.1097/EJA.0000000000000729
We recommend extended prophylaxis for patients with We recommend multi-faceted interventions for VTE
a high risk of VTE during the post-discharge period for prophylaxis in elderly and frail patients, including
10 to 15 days (Grade 1C). pneumatic compression devices, LMWH [and/or
direct oral anticoagulants (DOACs) after knee or hip
replacement] (Grade 1C).
Non-bariatric surgery
We suggest that in surgery with an indication for VTE Day surgery and fast-track surgery
Downloaded from http://journals.lww.com/ejanaesthesiology by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4
prophylaxis, a higher prophylactic dose of LMWH We recommend that all patients undergoing an
XMi0hCywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdtwnfKZBYtws= on 04/25/2023
(3000 to 4000 anti-Xa IU every 12 h subcutaneously) ambulatory/fast-track protocol should be assessed for
should be considered for obese patients with a BMI the VTE risk of the procedure and for any personal/
more than 40 kg m 2 undergoing non-bariatric surgery additional VTE risk (Grade 1B).4
(Grade 2C). For patients undergoing a low-risk procedure, without
For additional and general recommendations, we refer additional risk according to the Caprini score, we
to the section on ‘VTE prophylaxis of obese patients in recommend general measures of thromboprophylaxis
bariatric surgery’.1 (including early ambulation and optimal hydration)
over other specific measures (mechanical or pharma-
Surgery during pregnancy and the immediate cological) (Grade 1B).
post-partum period For patients undergoing a low-risk procedure with
Non-obstetric surgery during pregnancy additional risk factors, we recommend general mea-
We recommend thromboprophylaxis following surgery sures of thromboprophylaxis (e.g. early ambulation and
during pregnancy or the post-partum period, when optimal hydration) (Grade 1B). We suggest assessing
they imply, as a consequence, bed-rest, until full pharmacological prophylaxis with LMWH over other
mobility is recovered (Grade 1C).2 drugs (Grade 2B). We suggest the use of specific
We suggest that thromboprophylaxis should be used in mechanical measures (IPC devices) in patients with an
cases of perioperative infection during pregnancy or increased bleeding risk (Grade 2C).
the postpartum period (Grade 2C). For patients undergoing a high-risk procedure without
additional risk factors, we recommend general mea-
sures of thromboprophylaxis (e.g. early ambulation,
Caesarean section and optimal hydration) (Grade 1B). We suggest the
Thromboprophylaxis is recommended after caesarean administration of pharmacological prophylaxis with
section in all cases, except elective caesarean section in LMWH over other drugs (Grade 2B). We suggest
low-risk patients (Grade 1C), but there is no clear assessing specific mechanical measures (IPC) in
consensus on the definition of this population. patients with an increased bleeding risk (Grade 2C).
The duration of thromboprophylaxis following caesar- For patients undergoing a high-risk procedure with
ean section should be at least 6 weeks for high-risk additional risk factors, we recommend general mea-
patients, and at least 7 days for other patients requiring sures of thromboprophylaxis (e.g. early ambulation and
anticoagulation (Grade 1C). optimal hydration) and pharmacological prophylaxis
with LMWH over other drugs (Grade 1B), or specific
Surgery in the elderly mechanical measures (IPC) in patients with an
Age over 70 years is a risk factor for postoperative VTE increased bleeding risk (Grade 2C).
(Grade B).3 We suggest the use of aspirin for VTE prevention after
In elderly patients, we suggest identification of total hip arthroplasty, total knee arthroplasty and hip
comorbidities increasing the risk for VTE (e.g. conges- fracture surgery (high-risk orthopaedic procedures) in
tive heart failure, pulmonary circulation disorders, renal patients without high VTE risk (Grade 2C).
failure, lymphoma, metastatic cancer, obesity, arthritis, We suggest the use of aspirin for VTE prevention after
post-menopausal oestrogen therapy), and correction if low-risk orthopaedic procedures in patients with high
present (e.g. anaemia, coagulopathy) (Grade 2C). VTE risk, or other high-risk orthopaedic procedures
We suggest against bilateral knee replacement in (e.g. knee arthroscopy) in patients without high VTE
elderly and frail patients (Grade 2C). risk (Grade 2C).
We suggest timing and dosing of pharmacological VTE We recommend no pharmacological VTE prevention
prophylaxis as in the non-aged population (Grade 2C). after low-risk orthopaedic procedures in patients
In elderly patients with renal failure, low-dose without high VTE risk (Grade 1C).
unfractionated heparin (UFH) may be used or For pharmacological prophylaxis, we recommend a
weight-adjusted dosing of LMWH (Grade 2C). minimum of 7 days’ duration of treatment over
In the elderly, we recommend careful prescription of protocols lasting 3 days or single-dose protocols
postoperative VTE prophylaxis and early postopera- (Grade 1B), although in selected cases of fast-
tive mobilisation (Grade 1C). track surgery, thromboprophylaxis only during
after surgery (optimal time from 6 to 8 h after the end of mechanical prophylaxis using IPC (Grade 2C).6
XMi0hCywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdtwnfKZBYtws= on 04/25/2023
the procedure) (Grade 2C). In case of planned neuraxial The presence of one or more risk factors (age above 70
anaesthesia for the procedure, postoperative adminis- years, transfusion of more than four units of red blood
tration seems to be the preferred option (Grade 2C). cell concentrates/fresh frozen plasma/cryoprecipitate/
fibrinogen concentrate, mechanical ventilation more
Intensive care than 24 h, postoperative complication (e.g. acute
In critically ill patients, we recommend against the kidney injury, infection/sepsis, neurological complica-
routine use of compression duplex ultrasound screen- tion) should place the cardiac population at high
ing of deep vein thrombosis (DVT) (Grade 1B).5 risk for VTE. In this context, we suggest the use
We recommend an institution-wide protocol for the of pharmacologic prophylaxis as soon as satisfactory
prevention of VTE that includes the use of mechanical haemostasis has been achieved, in addition to IPC
thromboprophylaxis, that is IPC (Grade 1B). (Grade 2C).
For critically ill patients, we recommend using Patients undergoing other valve surgery and those with
thromboprophylaxis with LMWH or LDUH (Grade atrial fibrillation should be considered a specific entity
1B), and we recommend LMWH over LDUH (Grade at high risk of VTE, as they will mostly require
1B). postoperative therapeutic medical ‘bridging’ prior to
For VTE prophylaxis in critically ill patients with long-term anticoagulation.
severe renal insufficiency, we suggest the use of Patients undergoing peripheral vascular surgery are
LDUH (Grade 2C), dalteparin (Grade 2B) or reduced considered to have a low risk of VTE and a low risk of
doses of enoxaparin (Grade 2C). Monitoring of anti-Xa bleeding. Stringent medical prophylaxis appears to
activity may be considered when LMWH is used in reduce the event rate significantly. In this population,
these patients (Grade 2C). we suggest medical therapy (Grade 2C).
The use of pharmacological prophylaxis in patients In patients undergoing abdominal aortic aneurysm
with severe liver dysfunction should be carefully repair, particularly when an open surgical approach is
balanced against the risk of bleeding. If a treatment is used, the risk for VTE is higher, with a high bleeding
administered, the use of LDUH or LMWH is risk. These patients should be considered as having a
suggested (Grade 2C). moderate risk. Patients with additional risk factors,
We suggest no prophylaxis or the use of IPC in patients including BMI at least 30 kg m 2, preoperative
with a platelet count less than 50 109 l-1 and a high- dyspnoea, chronic steroid usage, ruptured aneurysm,
risk of bleeding (Grade 2C). open surgery, operative duration at least 5 h, transfu-
For critically ill patients, we recommend against the sion of at least 5 U, postoperative mechanical ventila-
routine use of inferior vena cava (IVC) filters for tion more than 48 h, postoperative complication (acute
the primary prevention of VTE (Grade 1C). We kidney injury, infection/sepsis) and re-operation,
suggest the use of IVC filters in patients who can should be considered as moderate to high risk. In
neither receive pharmacological prophylaxis nor IPC this context, we suggest the use of pharmacological
(Grade 2C). prophylaxis as soon as satisfactory haemostasis is
In critically ill patients with suspected or confirmed achieved (Grade 2C).
diagnosis of heparin-induced thrombocytopaenia We suggest that low-dose aspirin could be used to
(HIT), all forms of heparin must be discontinued decrease the incidence of VTE in cardiac and vascular
(Grade 1B). In these patients, immediate anticoagula- patients, but should not be considered as the sole agent
tion with a non-heparin anticoagulant rather than in high-risk patients. (Grade 2C).
discontinuation of heparin alone is recommended UFH is associated with the highest risk of developing
unless there is a strong contra-indication to anti- the prothrombotic condition of HIT. Therefore, in an
coagulation (Grade 1C). The selection of non-heparin attempt to minimise the risk of HIT, we suggest that
anticoagulants should be based on patient character- UFH should be used as briefly as possible and replaced
istics: argatroban is the first choice in case of renal by LMWH as soon as the bleeding risk decreases
insufficiency, and bivalirudin in patients undergoing (Grade 2C).
or after cardiac surgery (Grade 2C). The use of In patients with severely impaired renal function
fondaparinux can also be considered in these patients (Cockroft and Gault clearance <30 ml min 1) and a
(Grade 2C). high risk of haemorrhagic complications, we suggest
close monitoring of the administration of therapeutic For patients undergoing spinal surgery with additional
UFH and LMWH and adaptation of the dosage risk factors (limited mobility, active cancer, complex
(Grade 2C). surgical procedure), we recommend starting mecha-
nical thromboprophylaxis with IPC preoperatively
Thoracic surgery (Grade 1C), and we suggest the addition of LMWH
Based on the current literature, patients undergoing postoperatively when the risk of bleeding is presumed
thoracic surgery in the absence of cancer could be to be decreased (Grade 2C).
Downloaded from http://journals.lww.com/ejanaesthesiology by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4
considered at low risk of VTE. However, as the vast If LMWH is used, we recommend delayed initiation at
XMi0hCywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdtwnfKZBYtws= on 04/25/2023
majority of patients undergoing thoracic surgery have a least until 24 h after surgery and only when haemostasis
diagnosis of primary or metastatic cancer, they should occurs (Grade 1C).
be considered at high risk for VTE with an equally high We suggest continued thromboprophylaxis until
bleeding risk. discharge in high-risk patients (Grade 2C).
In the absence of evidence regarding patients In patients with spinal cord injury or significant motor
undergoing minimally invasive procedures, the same impairment, we suggest extending the thrombopro-
risk stratification should be applied as described above. phylaxis into the rehabilitation phase of hospital care
In low-risk patients, we suggest the use of mechanical (Grade 2C).
prophylaxis using IPC (Grade 2C). In high-risk
patients, we suggest the use of pharmacological Chronic treatments with anti-platelet agents
prophylaxis in addition to IPC (Grade 2B). In patients receiving anti-platelet agents (APA)
chronically, we recommend thromboprophylaxis in
Neurosurgery case of moderate/high VTE risk, whilst assessing the
Patients undergoing craniotomy risk of perioperative bleeding (Grade 1B).8
We recommend that if IPC is used, it should be applied In patients receiving APA chronically, if the risk of
before the surgical procedure or on admission, used VTE outweighs the risk of bleeding, we suggest
continuously (except when the patient is actually pharmacological (anticoagulant) prophylaxis (LMWH,
walking) and monitored frequently to optimise DOAC, fondaparinux, depending on the indication)
compliance (Grade 1C).7 (Grade 2C).
If LMWH or LDUH are used, we suggest delayed In patients treated with dual anti-platelet therapy
initiation until at least 24 h after surgery. (Grade 2C). (recent coronary stent implantation) undergoing a
In craniotomy patients at particularly high risk of VTE procedure associated with a high risk of VTE, we
(additional risk factors including malignancy, motor suggest resuming both APA shortly after the proce-
impairment, prolonged operative time), we suggest dure, prioritising over pharmacological VTE preven-
considering the initiation of mechanical thrombopro- tion (Grade 2C).
phylaxis with IPC preoperatively with addition of If an anti-coagulant is associated with an APA, we
LMWH or LDUH postoperatively when the risk of suggest the administration of the lowest approved dose
bleeding is presumed to be decreased (Grade 2C). (Grade 2C).
We suggest that thromboprophylaxis should be If the risk of bleeding of a combination of an APA
continued until discharge (Grade 2C). and an anticoagulant outweighs the risk of VTE, we
suggest considering IPC over anticoagulant prophy-
Patients with non-traumatic intra cranial laxis, without discontinuing the APA (Grade 2C).
haemorrhage Patients in whom neuraxial anaesthesia is planned,
We suggest thromboprophylaxis with IPC (Grade 2C). although the administration of aspirin alone does
We recommend the application of IPC on admission, not increase the incidence of spinal haematoma,
used continuously (except when the patient is actually a higher rate of complications could appear if
walking) and monitored frequently to optimise pharmacological thromboprophylaxis is administered
compliance (Grade 1C). concurrently. In these patients, postoperative throm-
For patients who have had non-traumatic intracranial boprophylaxis initiation should be suggested
haemorrhage, we suggest giving consideration to (Grade 2C).
commencement of LMWH or LDUH when the risk After surgery, the first dose of aspirin should be given
of bleeding is presumed to be low (Grade 2C). as soon as possible, once haemostasis is considered
We suggest continuing thromboprophylaxis until full adequate (in general, the day after surgery) (Grade 2B).
mobilisation of the patient (Grade 2C). In the case of clopidogrel, the main recommendation is
to give the drug without any loading dose between 24
Spinal surgery and 48 h after surgery (Grade 2C).
For patients with no additional risk factors, we suggest Monitoring for clinical signs of bleeding or un-
no active thromboprophylaxis intervention apart from explained anaemia is recommended during con-
early mobilisation (Grade 2C). comitant administration of an anticoagulant for
disorders and after severe perioperative VIII : C should be considered to minimise the risk of
XMi0hCywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdtwnfKZBYtws= on 04/25/2023
In cancer patients or patients with haematological We suggest combined mechanical and pharmacological
disorders and mild thrombocytopaenia (platelet count prophylaxis in selected patients at very high risk for
>80 109 l 1), pharmacological prophylaxis may be VTE (grade 2B). We suggest the use of IPC rather than
used; if the platelet count is below 80 109 l 1, GCS in selected high-risk patients in addition to
pharmacological prophylaxis may only be considered pharmacological thromboprophylaxis (Grade 2B).
on a case-by-case basis and careful monitoring is
recommended (Grade 2C). Aspirin
Downloaded from http://journals.lww.com/ejanaesthesiology by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4
Patients with a high thrombotic risk (e.g. mechanical We recommend the use of aspirin as an option for VTE
XMi0hCywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdtwnfKZBYtws= on 04/25/2023
heart valves) may benefit from resuming warfarin prevention after total hip arthroplasty, total knee
therapy despite ongoing risk for recurrent gastrointes- arthroplasty and hip fracture surgery (Grade 1B).11
tinal bleeding (Grade 2C). We suggest the use of aspirin for VTE prevention after
Patients with a HAS-BLED score lower than the total hip arthroplasty, total knee arthroplasty and hip
CHADS2 score may benefit from earlier resumption fracture surgery (high-risk procedures) in patients
(Grade 2C). without high VTE risk (Grade 2C).
The delay between major gastrointestinal bleeding We suggest the use of aspirin for VTE prevention after
and warfarin resumption should be at least 7 days low-risk orthopaedic procedures in patients with a high
(Grade 2C). VTE risk or other high-risk orthopaedic procedures in
We suggest International Normalised Ratio at the patients without a high VTE risk (Grade 2C).
time of bleeding may also be considered to resume We suggest the use aspirin for VTE prevention after
anticoagulation (Grade 2C). total hip arthroplasty, total knee arthroplasty and hip
We suggest resuming anticoagulant therapy 12 h fracture surgery in patients with an increased bleeding
after removal of drains in cases of cardiac tamponade risk (Grade 2C).
(Grade C). We suggest the use of aspirin for VTE prevention
When the risk of bleeding diminishes, pharmacological after total hip arthroplasty or total knee arthroplasty
VTE prophylaxis may be initiated depending on in a rapid recovery (fast-track) programme (Grade 2C).
thrombotic risk factors (Grade 2C). We recommend combining aspirin with IPC devices
We recommend that, when the risk of postoperative for VTE prevention after total hip arthroplasty, total
bleeding is higher than the risk of a thromboembolic knee arthroplasty and hip fracture surgery (Grade 1C).
event, full dose anticoagulation may be resumed 48 or We recommend no pharmacological VTE prevention
72 h after the procedure (Grade 2B). after low-risk orthopaedic procedure in patients
For patients at high risk for thromboembolism and with without high VTE risk (e.g. knee arthroscopy)
a high bleeding risk after surgery, we consider that (Grade 1C).
administering a reduced dose of DOAC on the evening No recommendation can be made concerning dose and
after surgery and on the following day (first postopera- duration of aspirin treatment and patient selection.
tive day) after surgery is good practice (Grade 2B). We do not recommend aspirin for thromboprophylaxis
in general surgery (grade 1C). However, this type of
Mechanical prophylaxis prophylaxis could be interesting, especially in low-
We recommend an institution-wide protocol for income countries (Grade 2C), and adequate large-scale
the prevention of VTE that integrates early ambula- trials with proper study designs should be carried out
tion, pharmacological thromboprophylaxis with (Grade 1C).
anticoagulants and mechanical thromboprophylaxis
(Grade IB).10 Inferior vena cava filters
We recommend against the routine use of graduated There is currently no clear evidence on the efficacy
compression stockings (GCS) without pharmacological and safety of IVC filters (IVCF) in patients with a
thromboprophylaxis to prevent VTE in patients at contra-indication for pharmacological and mechanical
intermediate and high risk (Grade IB). thromboprophylaxis undergoing high-thrombotic-risk
In patients with contra-indications to pharmacological surgery or procedures (Grade B).12
thromboprophylaxis, we recommend the use of IVCF-associated complications often seem to out-
mechanical prophylaxis with IPC or GCS (Grade IB) weigh a potential benefit (Grade B).
and suggest the use of IPC over GCS (Grade 2B). We suggest considering temporary IVCF placement in
In patients with contra-indications for pharmacological patients at high VTE risk when pharmacological and
thromboprophylaxis who are not at high risk for VTE, mechanical thromboprophylaxis are fully contra-indi-
we suggest no prophylaxis over GCS alone (Grade 2C). cated (Grade 2C).
In patients receiving pharmacological thromboprophy- We suggest considering temporary IVCF placement in
laxis who are not at very high risk for VTE, we patients with documented recent DVT, and with an
recommend against the routine use of mechanical absolute contra-indication for full anticoagulation and
thromboprophylaxis with GCS or IPC (Grade IB). planned non-deferrable major surgery (Grade 2C).
We suggest not systematically using IVCFs to prevent 4 Venclauskas L, Llau JV, Jenny J-Y, et al., for the ESA VTE Guidelines Task
Force. European guidelines on perioperative venous thromboembolism
pulmonary embolism in the perioperative setting prophylaxis. Day surgery and fast-track surgery. Eur J Anaesthesiol 2018;
(Grade 2B). 35:134–138.
5 Duranteau J, Taccone FS, Verhamme P, et al., for the ESA VTE Guidelines
Task Force. European guidelines on perioperative venous
Acknowledgements related to this article thromboembolism prophylaxis. Intensive Care. Eur J Anaesthesiol 2018;
Assistance with the guidelines: none. 35:142–146.
6 Ahmed AB, Koster A, Lance M, et al., for the ESA VTE Guidelines Task
Downloaded from http://journals.lww.com/ejanaesthesiology by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4
Financial support and sponsorship: expenses for two meetings of Force. European guidelines on perioperative venous thromboembolism
the VTE Task Force (Brussels and Berlin) were covered by the prophylaxis. Cardiovascular and thoracic surgery. Eur J Anaesthesiol
XMi0hCywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdtwnfKZBYtws= on 04/25/2023